INDOLENT LYMPHOMA

Clinical trials for INDOLENT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INDOLENT LYMPHOMA trials appear

Sign up with your email to follow new studies for INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

New hope for Tough-to-Treat blood cancer: experimental drug trial opens

Disease control Recruiting now

This study is testing an oral drug called pacritinib for people with Waldenström macroglobulinemia, a rare blood cancer, that has come back or stopped responding to other treatments. The drug works by blocking specific proteins that help the cancer cells survive and grow. About 3…

Matched conditions: INDOLENT LYMPHOMA

Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control

Last updated Apr 04, 2026 07:35 UTC

INDOLENT LYMPHOMA

Get alerted when new INDOLENT LYMPHOMA trials appear

New hope for Tough-to-Treat blood cancer: experimental drug trial opens